Omega Therapeutics Inc (NAS:OMGA)
$ 0.8299 0.0079 (0.96%) Market Cap: 45.95 Mil Enterprise Value: 143.27 Mil PE Ratio: 0 PB Ratio: 3.97 GF Score: 31/100

Omega Therapeutics Inc at Chardan Genetic Medicines Conference Transcript

Oct 03, 2023 / 03:30PM GMT
Release Date Price: $1.7 (-10.32%)
Keay Nakae
Chardan - Moderator

It's my pleasure to introduce our next guest from Omega Therapeutics: CEO Mahesh Karande, and CSO, Dr. Tom McCauley. Gentlemen, thank you for being with us today. Mahesh, maybe to start, can you provide an overview for the company and maybe talk about some of your key accomplishments in 2023 year to date?

Questions & Answers

Mahesh Karande
Omega Therapeutics Inc - CEO,President,Director

Absolutely Keay. First of all, thanks a lot for having us at this conference and at this fireside chat, and thanks to you and Chardan. We are really excited to talk about Omega because Omega, as you know, as a company -- we just came out with clinical data in our first program for OTX-2002 in hepatocellular carcinoma.

And the reason these data are extremely significant is -- first of all, I mean, we'll talk more about the data, I'm sure -- but first of all, at this early stage, we are seeing a mechanism of action. So clinical proof of mechanism of action and mechanism of our platform in eight on eight patients. That is the the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot